ClinicalTrials.Veeva

Menu

Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?

T

Tepecik Training and Research Hospital

Status

Completed

Conditions

Neural Tube Defects
Newborn Sepsis

Treatments

Diagnostic Test: Neutrophil to lymphocyte ratio

Study type

Observational

Funder types

Other

Identifiers

NCT04135274
2018/12- 7

Details and patient eligibility

About

We aimed to investigate whether Neutrophil Lymphocyte Ratio is a Prognostic Factor of Sepsis in Newborns with operated Neural Tube Defects?

Enrollment

57 patients

Sex

All

Ages

Under 28 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • <28 days diagnosed with with neural Tüpe Defects To be operated

Exclusion criteria

  • >28 days

Trial design

57 participants in 2 patient groups

Sepsis group
Treatment:
Diagnostic Test: Neutrophil to lymphocyte ratio
Non Sepsis group
Treatment:
Diagnostic Test: Neutrophil to lymphocyte ratio

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems